Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Sale
Global Canine Arthritis Treatment Market: By Treatment: Non-Steroidal Anti-Inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Others; By Route of Administration: Oral, Injectable; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments
Global Canine Arthritis Treatment Market Outlook
The global canine arthritis treatment market stood at a value of nearly USD 2 billion in 2020. The market is further expected to grow at a CAGR of 5% in the forecast period of 2021-2026.
North America Dominates the Canine Arthritis Treatment Industry Globally
North America is the leading canine arthritis treatment market globally and the region is expected to maintain its dominance in the forecast period as well. The growth can be attributed to the increased pet adoptions and the high expenditure on pet care in the region. Within North America, the United States significantly contributes to the industry growth. According to the American Pet Products Association, the US pet owners spent over USD 7.4 billion on vet care in 2017. This demonstrates high awareness regarding the health of pet among the general population in the region. Europe follows North America in terms of market value, with around USD 6.1 billion spending on vet care in the same year. Meanwhile, the Asia Pacific is expected to witness a relatively higher growth in the forecast period owing to the expanding pet care market in emerging nations like India. The growing awareness regarding canine arthritis treatment in such regions are expected to provide enhanced growth opportunities to the market in the coming years.
Canine Arthritis Treatment: Industry Definition and Segmentation
Canine arthritis is a medical condition in pets that results in inflammation in joints, thereby affecting knee, elbow, spinal cord, and other joints. Some of the causes of canine arthritis in dogs include accidental injuries, obesity, repetitive stress from athletic activities, and improper nutrition. The lack of treatment can lead to a substantial increase in inflammation and pain and decreased range of motion. However, early detection of problem and its proper management can help pets to remain active. The most common form of arthritis is osteoarthritis, which is commonly known as degenerative joint disease (DJD). Generally, osteoarthritis treatment is multimodal, that is, it involves the use of several different therapies simultaneously to achieve the best result. The treatment is typically focused on reducing pain, controlling inflammation, improving quality of life, and slowing the development of the disease.
By treatment, the market is divided into:
- Non-Steroidal Anti-Inflammatory Medications (NSAIDs)
- Opioids
- Stem Cell Therapy
- Others
The market is divided based on route of administration into:
- Oral
- Injectable
On the basis of distribution channel, the industry can be segmented into:
- Veterinary Hospitals and Clinics
- Retail Pharmacies
- Online
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Rising Prevalence of Osteoarthritis in Dogs and the Growing Pet Care Market to Bolster the Growth of the Canine Arthritis Treatment Industry
The increasing incidences of arthritis in dogs, particularly osteoarthritis, is the major factor driving the growth of the canine arthritis treatment industry. Osteoarthritis affects as many as one in five dogs and is a common problem in older dogs and large breeds. The development of osteoarthritis in pets can be prevented through proper diet, exercise, and the use of protective joint supplements. The canine arthritis treatment industry is further supported by the growing pet care market, particularly in developing nations like India. Over the forecast period, increasing awareness regarding canine arthritis treatment is expected to further accelerate the market growth.
Due to the outbreak of the COVID-19 pandemic, nonessential vet visits have been restricted, however, there has been a spike in adoption of pets and foster applications in 2020. The shelters across the United States have reported a rise in foster applications as people prepare to spend more time at home amidst the lockdown. This is expected to aid the industry growth in the forecast period.
Key Industry Players in the Global Canine Arthritis Treatment Market
The report gives a detailed analysis of the following key players in the global canine arthritis treatment industry, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Boehringer Ingelheim (Canada) Ltd.
- America Regent, Inc.
- Elanco Animal Health Incorporated
- Zoetis Services LLC
- American Regent, Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Canine Arthritis Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Canine Arthritis Treatment Historical Market (2016-2020)
8.3 Global Canine Arthritis Treatment Market Forecast (2021-2026)
8.4 Global Canine Arthritis Treatment Market by Treatment
8.4.1 Non-Steroidal Anti-Inflammatory Medications (NSAIDs)
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Opioids
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Stem Cell Therapy
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.4.4 Others
8.5 Global Canine Arthritis Treatment Market by Route of Administration
8.5.1 Oral
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Injectable
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.6 Global Canine Arthritis Treatment Market by Distribution Channel
8.6.1 Veterinary Hospitals and Clinics
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Retail Pharmacies
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Online
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 Others
8.7 Global Canine Arthritis Treatment Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Boehringer Ingelheim (Canada) Ltd.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 America Regent, Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Elanco Animal Health Incorporated
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Zoetis Services LLC
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 American Regent, Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Canine Arthritis Treatment Market: Key Industry Highlights, 2016 and 2026
2. Global Canine Arthritis Treatment Historical Market: Breakup by Treatment (USD Billion), 2016-2020
3. Global Canine Arthritis Treatment Market Forecast: Breakup by Treatment (USD Billion), 2021-2026
4. Global Canine Arthritis Treatment Historical Market: Breakup by Route of Administration (USD Billion), 2016-2020
5. Global Canine Arthritis Treatment Market Forecast: Breakup by Route of Administration (USD Billion), 2021-2026
6. Global Canine Arthritis Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2016-2020
7. Global Canine Arthritis Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2021-2026
8. Global Canine Arthritis Treatment Historical Market: Breakup by Region (USD Billion), 2016-2020
9. Global Canine Arthritis Treatment Market Forecast: Breakup by Region (USD Billion), 2021-2026
10. North America Canine Arthritis Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
11. North America Canine Arthritis Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
12. Europe Canine Arthritis Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
13. Europe Canine Arthritis Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
14. Asia Pacific Canine Arthritis Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
15. Asia Pacific Canine Arthritis Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
16. Latin America Canine Arthritis Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
17. Latin America Canine Arthritis Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
18. Middle East and Africa Canine Arthritis Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
19. Middle East and Africa Canine Arthritis Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
20. Global Canine Arthritis Treatment Market Structure
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 1999
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst SupportFree Update in 180 DaysSingle User License
$3099$2499-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst SupportFree Update in 180 DaysFive User License
$4099$3499-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
Free Update in 180 Days
Corporate License
$5099$4499-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
Free Update in 180 Days
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar ReportsThe global diuretic drugs therapy market is being aided by the growing antihypertensive drugs market, which reached a value of about USD 28 billion in 2020. The antihypertensive drugs industry is furt...
The global pigmentation disorder treatment market is being driven by the rising ageing population. Aided by the rapid advances in tissue engineering and the adoption of novel techniques, the industry ...
The global intraocular melanoma treatment market is being driven by the rising eye cancer market. Aided by the technological advancements, the eye cancer market is expected to witness a healthy growth...
The global traveller’s diarrhoea treatment market is being driven by the rising tourism sector. Aided by the growing awareness about the disease, the market is expected to witness a healthy growth i...
The global bullous pemphigoid treatment market is being driven by the rising skin disease treatment market, which attained a value of USD 19 billion in 2020. The skin disease treatment market is expec...
NEWSLETTER